Agenus
Price & Volume
Stats
See moreOpen | $1.67 |
Previous Close | $1.69 |
Day Range | $1.60-$1.68 |
52W Range | $1.38-$19.68 |
Market Cap | $42.7M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $103.4M |
Revenue Growth (YoY) | -68% |
Gross Profit (12 Mos) | -$52.5M |
Diluted EPS | -$10.59 |
News
See moreYahoo Finance • 7 months ago
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
Yahoo Finance • 8 months ago
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
Yahoo Finance • last year
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
Yahoo Finance • last year
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
About
CEO | Dr. Garo H. Armen Ph.D. |
Address | 3 Forbes Road, Lexington, MA, United States, 02421-7305 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 316 |
